Home » SAMARITAN'S MARKETING AUTHORIZATION APPLICATION FOR AMPHOCIL APPROVED IN GREECE
SAMARITAN'S MARKETING AUTHORIZATION APPLICATION FOR AMPHOCIL APPROVED IN GREECE
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification by the National Pharmaceuticals Organization, (EOF) for a new marketing authorization for Amphocil in Greece. The National Pharmaceutical Organization, (EOF), is the competent authority for granting approval to market pharmaceutical and medical products in Greece, similar to the FDA in the United States. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=103241)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May